Journal of cardiovascular electrophysiology
-
J. Cardiovasc. Electrophysiol. · Dec 2011
Multicenter StudyPacemaker and implantable cardioverter-defibrillator use in a US myotonic dystrophy type 1 population.
We assessed implant rates, indications, characteristics, and outcomes in patients with the neuromuscular disease, myotonic dystrophy type 1 (DM1) receiving a pacemaker or an implantable cardioverter-defibrillator (ICD). ⋯ DM1 patients commonly receive antiarrhythmia devices. The risk of VT/VF and sudden death suggests that ICDs rather than pacemakers should be considered for these patients.
-
J. Cardiovasc. Electrophysiol. · Dec 2011
Deep sedation for catheter ablation of atrial fibrillation: a prospective study in 650 consecutive patients.
Catheter ablation of atrial fibrillation (AF) is a highly invasive and relatively long-lasting procedure with specific requirements for patient sedation. The feasibility and safety of deep sedation is described in a prospective study of 650 consecutive patients. ⋯ Deep sedation for catheter ablation of AF is feasible and safe. Especially, the goal of keeping the patient in deep sedation while maintaining spontaneous ventilation and cardiovascular hemodynamic stability was accomplished. Endotracheal intubation or consultation of an anesthesiologist was not necessary in any patient.